Encompass Health Corporation $EHC Shares Acquired by Alliancebernstein L.P.

Alliancebernstein L.P. lifted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 23.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,515,878 shares of the company’s stock after buying an additional 476,564 shares during the period. Alliancebernstein L.P. owned approximately 2.50% of Encompass Health worth $319,567,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in EHC. Citizens National Bank Trust Department purchased a new position in Encompass Health in the 3rd quarter worth $26,000. First Horizon Corp purchased a new stake in Encompass Health during the 3rd quarter valued at about $34,000. Westside Investment Management Inc. increased its holdings in shares of Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after purchasing an additional 101 shares during the period. Assetmark Inc. increased its holdings in shares of Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after purchasing an additional 140 shares during the period. Finally, Root Financial Partners LLC purchased a new position in shares of Encompass Health in the third quarter worth about $39,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Up 0.2%

Shares of EHC stock opened at $100.52 on Monday. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The stock has a market cap of $9.99 billion, a P/E ratio of 18.14, a P/E/G ratio of 1.92 and a beta of 0.70. The stock has a 50 day moving average of $103.58 and a 200 day moving average of $112.90. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.29 by $0.17. The business had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, sell-side analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a $0.19 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s payout ratio is 13.72%.

Analyst Ratings Changes

A number of brokerages recently commented on EHC. Barclays upped their target price on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $143.29.

Insider Activity at Encompass Health

In other news, CEO Mark J. Tarr sold 150,000 shares of Encompass Health stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the sale, the chief executive officer owned 377,070 shares in the company, valued at $42,096,094.80. This trade represents a 28.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.